646 related articles for article (PubMed ID: 17703923)
1. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
2. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
[TBL] [Abstract][Full Text] [Related]
3. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
[TBL] [Abstract][Full Text] [Related]
4. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
Sidorenko SV; Gel'fand EB; Mamontova OA
Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
6. The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.
Tsukayama DT; van Loon HJ; Cartwright C; Chmielewski B; Fluit AC; van der Werken C; Verhoef J;
Int J Antimicrob Agents; 2004 Oct; 24(4):339-45. PubMed ID: 15380258
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
8. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
Pierson CL; Friedman BA
Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of a computerized expert system associated with systematic O-serotyping for the early detection of outbreaks of hospital acquired infections and for the presumptive antibiotic therapy of Pseudomonas aeruginosa infections.
Watine J; Charet JC; Bruel A; Bouilloux JP; Palliez J
Pathol Biol (Paris); 1996 Feb; 44(2):125-31. PubMed ID: 8761597
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
Dubois V; Arpin C; Melon M; Melon B; Andre C; Frigo C; Quentin C
J Clin Microbiol; 2001 Jun; 39(6):2072-8. PubMed ID: 11376037
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.
Paladino JA; Sunderlin JL; Forrest A; Schentag JJ
J Antimicrob Chemother; 2003 Sep; 52(3):457-63. PubMed ID: 12888598
[TBL] [Abstract][Full Text] [Related]
12. Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli.
Toltzis P; Dul M; O'Riordan MA; Salvator A; Rosolowski B; Toltzis H; Blumer JL
Pediatr Infect Dis J; 2003 Feb; 22(2):109-14. PubMed ID: 12586972
[TBL] [Abstract][Full Text] [Related]
13. The choice of empirical antibiotic therapy for nosocomial pneumonia.
Ramirez JA
J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054
[TBL] [Abstract][Full Text] [Related]
14. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility of Pseudomonas aeruginosa isolated from hospital infections to antibiotics].
Gniadkowski M; Skoczyńska A; Fiett J; Trzciński K; Hryniewicz W
Pol Merkur Lekarski; 1998 Dec; 5(30):346-50. PubMed ID: 10101521
[TBL] [Abstract][Full Text] [Related]
16. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
Nichols L; Maki DG
Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
[TBL] [Abstract][Full Text] [Related]
17. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.
Raymond DP; Pelletier SJ; Crabtree TD; Evans HL; Pruett TL; Sawyer RG
Crit Care Med; 2003 Apr; 31(4):1035-41. PubMed ID: 12682469
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa isolates from different medical institutions.
Nitzan Y; Sharon R; Maayan M; Steuerman C
Isr J Med Sci; 1985 Oct; 21(10):798-803. PubMed ID: 3935600
[TBL] [Abstract][Full Text] [Related]
19. [Pseudomonas aeruginosa: a multicenter study in 136 hospitals in Spain].
Bouza E; Garcia-Garrote F; Cercenado E; Marín M; Díaz MS; Sánchez Romero I; Vindel A;
Rev Esp Quimioter; 2003 Mar; 16(1):41-52. PubMed ID: 12750756
[TBL] [Abstract][Full Text] [Related]
20. [Choice of a rapidly bactericidal beta-lactamin-aminoglycoside combination in the treatment of Pseudomonas aeruginosa infections at a child intensive care unit].
Lambert-Zechovsky N; Bingen E; Guihaire E; Mancy C; Mercier JC; Beaufils F
Pathol Biol (Paris); 1986 Sep; 34(7):855-8. PubMed ID: 3537930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
